Maia, Portugal

Sónia Melo

USPTO Granted Patents = 4 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Location History:

  • Porto, PT (2018)
  • Oponto, PT (2020)
  • Maia, PT (2021)
  • Oporto, PT (2024)

Company Filing History:


Years Active: 2018-2024

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Sónia Melo: Innovator in Cancer Diagnosis and Therapy

Introduction

Sónia Melo is a prominent inventor based in Maia, Portugal. He has made significant contributions to the field of cancer research, particularly in the use of exosomes for diagnosis and therapy. With a total of 4 patents, Melo's work is at the forefront of innovative medical solutions.

Latest Patents

Melo's latest patents include groundbreaking methods for diagnosing and treating cancers through the use of exosomes. One notable patent focuses on miRNA biogenesis in exosomes for diagnosis and therapy. This method allows for the diagnosis or evaluation of cancer by determining the miRNA content of exosomes in a sample from a subject or by detecting miRNA processing in exosomes. Another significant invention involves lipid-based nanoparticles, such as liposomes or exosomes, that have CD47 on their surface and comprise a therapeutic agent. This invention provides new avenues for therapy using these lipid-based nanoparticles.

Career Highlights

Throughout his career, Sónia Melo has worked with esteemed institutions, including the University of Texas System and Beth Israel Deaconess Medical Center, Inc. His research has been instrumental in advancing the understanding of exosomes in cancer treatment.

Collaborations

Melo has collaborated with notable professionals in his field, including Raghu Kalluri, enhancing the impact of his research through shared expertise.

Conclusion

Sónia Melo's innovative work in cancer diagnosis and therapy exemplifies the potential of exosomes in medical science. His contributions continue to pave the way for new therapeutic strategies in oncology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…